Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline in Intracerebral Hemorrhage
NCT07305896Not yet recruiting
- Sponsor
- The First Hospital of Jilin University
- Start
- Dec 2025
- Primary completion
- Dec 2028
- Modality
- Small Molecules
01
Overview
Randomised, single-blind trial of minocycline in intracerebral hemorrhage (ICH) (2 arms), sponsored by The First Hospital of Jilin University. Primary endpoint: Proportion of patients with favorable functional outcomes (mRS 0-2) at 180 days. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
minocycline
03
Conditions
intracerebral hemorrhage (ICH)
Beyond the preview
Go deeper on NCT07305896.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07305896.